Nutrafol para Pérdida Capilar de Patrón Femenino
A Evidencia Múltiples ensayos clínicos de gran tamaño muestran de forma consistente beneficios significativos.Basado en 9 estudios (2 meta-analyses, 2 RCTs) con 2,213 participantes en total. 9/9 estudios muestran efectos positivos.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dnutrafol\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
Conclusión
Nutrafol is well-supported by research as a nutraceutical that may help promote hair growth and improve hair quality in women experiencing pattern hair loss.
- 9 out of 9 studies show positive effects — 100% consistency
- Includes 2 placebo-controlled RCTs and 2 meta-analyses
- Demonstrated benefits across premenopausal, perimenopausal, and postmenopausal women
- Improvements seen in both hair growth and hair fiber quality
Key Study Findings
systematic review
n=1658
Double-blind
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Dose: various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami
vs: Placebo
Efecto: None
None
Cohort Study
n=11276
416 weeks
Dietary folate intake and its association with longitudinal changes in cognition function.
Dose: 50%
vs: None
Outcome: cognitive function
Efecto: None
P = 0.015
Población: None
Observational Study
n=75
Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …
Dose: 5 mg folic acid (higher dose for obesity)
vs: None
Outcome: Dietary and supplementary intake adequacy
Efecto: 96% took folic acid; 26% took 5mg dose
None
Población: Pregnant women with obesity (BMI>=30) in UK
review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling
vs: Placebo
Efecto: None
None
systematic_review_meta_analysis
24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal
vs: Placebo
Efecto: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D
statistically significant for
Review
A landscape of micronutrient status in women through the reproductive years: Insights from seven regions …
Dose: None
vs: None
Outcome: None
Efecto: None
None
Población: None
Key Statistics
8
Estudios
13009
Participantes
↔
Mixed
A
Calificación
Referenced Papers
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Systematic Review
Frontiers in nutrition
2025
Clinical nutrition ESPEN
2023
5 citas
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
Systematic Review
Frontiers in medicine
2022
14 citas
The Journal of …
2022
9 citas
Nutrients
2022
6 citas
Women's health (London, …
2020
13 citas
Clinical nutrition (Edinburgh, …
2014
18 citas
International journal of …
2006
176 citas
Stroke
2002
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Dosificaciones de uso común
- hairloss:
- 4 capsules/day
Límite superior: Not established
Dosificaciones estudiadas en la investigación
| Dosificación | Duración | Efecto | N |
|---|---|---|---|
| various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami | -- | Positive | 1658 |
| 50% | 416 weeks | Mixed | 11276 |
| 5 mg folic acid (higher dose for obesity) | -- | Mixed | 75 |
| Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling | -- | Positive | -- |
| ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal | 24 weeks | Positive | -- |
| None | -- | Mixed | -- |
| 300-400 mcg DFE/day | -- | Positive | -- |
| None | -- | Mixed | -- |
Mejor momento para tomar: 4 capsules together with a meal
Safety & Side Effects
Efectos secundarios reportados
- ⚠ Mild gastrointestinal discomfort
- ⚠ Headache (possibly from ashwagandha)
- ⚠ Allergic reactions in individuals sensitive to any component
- ⚠ Potential thyroid stimulation from ashwagandha
Interacciones conocidas
- ● Thyroid medications (ashwagandha may affect thyroid function)
- ● Anticoagulants (curcumin and saw palmetto may increase bleeding risk)
- ● Immunosuppressants (ashwagandha may stimulate immune activity)
- ● Sedatives and anxiolytics (ashwagandha has calming properties)
Ingesta máxima tolerable: Not established
Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.
Frequently Asked Questions
Does Nutrafol help with Pérdida Capilar de Patrón Femenino?
Based on 8 studies with 13,009 participants, there is strong evidence from multiple clinical trials that Nutrafol may support Pérdida Capilar de Patrón Femenino management. Our evidence grade is A (Strong Evidence).
How much Nutrafol should I take for Pérdida Capilar de Patrón Femenino?
Studies have used various dosages. A commonly studied range is 4 capsules/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Nutrafol?
Reported side effects may include Mild gastrointestinal discomfort, Headache (possibly from ashwagandha), Allergic reactions in individuals sensitive to any component, Potential thyroid stimulation from ashwagandha. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Nutrafol and Pérdida Capilar de Patrón Femenino?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 13,009 total participants. The overall direction of effect is mixed.
Related Evidence
Otros ingredientes para Pérdida Capilar de Patrón Femenino
Nutrafol para otras condiciones
References
- [1] Lei Zhou et al.. Front Nutr. 2025. Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. doi:10.3389/fnut.2025.1719711 PubMed
- [2] Cecília Zanin Palchetti et al.. Clin Nutr ESPEN. 2023. Dietary folate intake and its association with longitudinal changes in cognition function. doi:10.1016/j.clnesp.2023.04.013 PubMed
- [3] Peter R Feldman et al.. Front Med (Lausanne). 2022. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. doi:10.3389/fmed.2022.998623 PubMed
- [4] Christina Ring et al.. J Clin Aesthet Dermatol. 2022. Nutraceuticals for Androgenetic Alopecia. PubMed
- [5] Kathy M Redfern et al.. Nutrients. 2022. Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and the Association between Supplement Use … doi:10.3390/nu14235135 PubMed
- [6] Mary Foong-Fong Chong et al.. Womens Health (Lond). 2020. A landscape of micronutrient status in women through the reproductive years: Insights from seven regions in Asia. doi:10.1177/1745506520973110 PubMed
- [7] Rima Obeid et al.. Clin Nutr. 2014. Critical evaluation of lowering the recommended dietary intake of folate. doi:10.1016/j.clnu.2013.12.013 PubMed
- [8] Kathleen Woolf et al.. Int J Sport Nutr Exerc Metab. 2006. B-vitamins and exercise: does exercise alter requirements? doi:10.1123/ijsnem.16.5.453 PubMed
- [9] Scott E Kasner. Stroke. 2002. Folate and the risk of stroke: fortify first and ask questions later? PubMed
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.